Literature DB >> 27755912

Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study.

Neema Jamshidi1, Danshan Huang1, Fereidoun G Abtin1, Christopher T Loh1, Stephen T Kee1, Robert D Suh1, Shota Yamamoto1, Kingshuk Das1, Sarah Dry1, Scott Binder1, Dieter R Enzmann1, Michael D Kuo1.   

Abstract

Purpose To identify the variables and factors that affect the quantity and quality of nucleic acid yields from imaging-guided core needle biopsy. Materials and Methods This study was approved by the institutional review board and compliant with HIPAA. The authors prospectively obtained 232 biopsy specimens from 74 patients (177 ex vivo biopsy samples from surgically resected masses were obtained from 49 patients and 55 in vivo lung biopsy samples from computed tomographic [CT]-guided lung biopsies were obtained from 25 patients) and quantitatively measured DNA and RNA yields with respect to needle gauge, number of needle passes, and percentage of the needle core. RNA quality was also assessed. Significance of correlations among variables was assessed with analysis of variance followed by linear regression. Conditional probabilities were calculated for projected sample yields. Results The total nucleic acid yield increased with an increase in the number of needle passes or a decrease in needle gauge (two-way analysis of variance, P < .0001 for both). However, contrary to calculated differences in volume yields, the effect of needle gauge was markedly greater than the number of passes. For example, the use of an 18-gauge versus a 20-gauge biopsy needle resulted in a 4.8-5.7 times greater yield, whereas a double versus a single pass resulted in a 2.4-2.8 times greater yield for 18- versus 20-gauge needles, respectively. Ninety-eight of 184 samples (53%) had an RNA integrity number of at least 7 (out of a possible score of 10). Conclusion With regard to optimizing nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there should be a preference for using lower gauge needles over higher gauge needles with more passes. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 21, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27755912     DOI: 10.1148/radiol.2016132230

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.

Authors:  Elliot B Levy; Maria I Fiel; Stanley R Hamilton; David E Kleiner; Shannon J McCall; Peter Schirmacher; William Travis; Michael D Kuo; Robert D Suh; Alda L Tam; Shaheen U Islam; Katherine Ferry-Galow; Rebecca A Enos; James H Doroshow; Hala R Makhlouf
Journal:  J Clin Oncol       Date:  2020-03-05       Impact factor: 44.544

2.  Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.

Authors:  Emily B Tsai; Kelsey Pomykala; Kathleen Ruchalski; Scott Genshaft; Fereidoun Abtin; Antonio Gutierrez; Hyun J Kim; Alice Li; Carlos Adame; Ashkan Jalalian; Brian Wolf; Edward B Garon; Jonathan W Goldman; Robert Suh
Journal:  Radiology       Date:  2017-12-12       Impact factor: 11.105

Review 3.  Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine.

Authors:  Miyuki Sone; Shunsuke Sugawara; Yasushi Yatabe
Journal:  Curr Oncol Rep       Date:  2022-04-01       Impact factor: 5.945

Review 4.  Ultrasound-guided biopsy of challenging abdominopelvic targets.

Authors:  Edward M Lawrence; Meghan G Lubner; Perry J Pickhardt; Michael P Hartung
Journal:  Abdom Radiol (NY)       Date:  2021-07-28

5.  Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.

Authors:  Miyuki Sone; Yasuaki Arai; Shunsuke Sugawara; Takatoshi Kubo; Chihiro Itou; Tetsuya Hasegawa; Noriyuki Umakoshi; Noboru Yamamoto; Kumiko Sunami; Nobuyoshi Hiraoka; Takashi Kubo
Journal:  Ups J Med Sci       Date:  2019-04       Impact factor: 2.384

6.  Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics.

Authors:  Mikhail T Silk; Nina Mikkilineni; Tarik C Silk; Emily C Zabor; Irina Ostrovnaya; Ari A Hakimi; James J Hsieh; Etay Ziv; Natasha Rekhtman; Stephen B Solomon; Jeremy C Durack
Journal:  Anal Cell Pathol (Amst)       Date:  2018-12-10       Impact factor: 2.916

7.  CT-guided transthoracic needle biopsy for evaluation of PD-L1 expression: Comparison of 22C3 and SP263 assays.

Authors:  Kyongmin S Beck; Seung Joon Kim; Jin Hyoung Kang; Dae Hee Han; Jung Im Jung; Kyo Young Lee
Journal:  Thorac Cancer       Date:  2019-06-24       Impact factor: 3.500

8.  Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer.

Authors:  Florian J Fintelmann; Fabian M Troschel; Martin W Kuklinski; Shaunagh McDermott; Milena Petranovic; Subba R Digumarthy; Amita Sharma; Amelie S Troschel; Melissa C Price; Lida P Hariri; Matthew D Gilman; Joanne O Shepard; Lecia V Sequist; Zofia Piotrowska
Journal:  Oncologist       Date:  2019-05-31

9.  Value of low-dose and optimized-length computed tomography (CT) scan in CT-guided percutaneous transthoracic needle biopsy of pulmonary nodules.

Authors:  Hui Yuan; Da Li; Yan Zhang; Xiaozhen Xie; Lujun Shen
Journal:  J Interv Med       Date:  2021-05-21

10.  Computed Tomography-Guided Transthoracic Needle Biopsy: Predictors for Diagnostic Failure and Tissue Adequacy for Molecular Testing.

Authors:  Chia-Ying Lin; Chao-Chun Chang; Chang-Yao Chu; Li-Ting Huang; Ta-Jung Chung; Yi-Sheng Liu; Yi-Ting Yen
Journal:  Front Med (Lausanne)       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.